[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@BrillResearch Brill Research
Brill Research posts on X about $vktx, $sofi, $unh, eps the most. They currently have XXXXX followers and XXX posts still getting attention that total XXX engagements in the last XX hours.
Engagements: XXX #
- X Week XXXXX -XX%
- X Month XXXXXX +929%
- X Months XXXXXX +22%
- X Year XXXXXX +11%
Mentions: X #
Followers: XXXXX #
- X Week XXXXX +0.34%
- X Month XXXXX +1.70%
- X Months XXXXX +2.50%
- X Year XXXXX +2.50%
CreatorRank: XXXXXXXXX #
Social Influence #
Social category influence stocks finance technology brands cryptocurrencies
Social topic influence $vktx, $sofi, $unh, eps, approved, $akba, Sentiment, $vik, $90100share, $ups
Top assets mentioned Viking Therapeutics, Inc (VKTX) RAI Finance (SOFI) UnitedHealth Group (UNH) Viking Holdings Ltd (VIK) United Parcel Service, Inc. (UPS) PayPal Holdings Inc (PYPL) Merck & Co., Inc. (MRK) Bitcoin (BTC) Ethereum (ETH) Hundred Million (100M) Bristol-Myers Squibb Co (BMY) Moderna Inc (MRNA)
Top Social Posts #
Top posts by engagements in the last XX hours
"$SOFI Medium-Term Outlook Maintained - 2026 EPS Target: $0.55-$0.80 range maintained Revenue Growth: Expect to exceed XX% CAGR from 2023-2026"
@BrillResearch on X 2025-07-30 09:49:48 UTC 2640 followers, XX engagements
"$VKTX Buyout/Medium-term PT remains at $90-100/share" @BrillResearch on X 2025-07-24 11:07:50 UTC 2638 followers, XXX engagements
"Tomorrow will be an exciting earnings day with $SOFI $UNH $PYPL $MRK and $UPS reporting" @BrillResearch on X 2025-07-28 19:42:30 UTC 2638 followers, XXX engagements
"$SOFI - Crypto Trading Return: Buy sell and hold cryptocurrencies like Bitcoin and Ethereum. Survey shows XX% of crypto-investing members prefer working with nationally licensed bank like SoFi" @BrillResearch on X 2025-07-30 09:49:47 UTC 2640 followers, XX engagements
"$AKBA expects Vafseo to become standard of care in the $X billion dialysis market. The NDD (non-dialysis) market offers a larger $X billion+ opportunity. After Vafseo's approval for dialysis which made $AKBA profitable phase III trials for NDD remain a significant catalyst" @BrillResearch on X 2025-07-12 12:00:40 UTC 2639 followers, 1239 engagements
"$UNH UnitedHealths Q2 results paint a picture of solid top-line growth overshadowed by sharp margin erosion driven by rising healthcare utilization and mispricing in Medicare Advantage. While revenues were healthy profit delivery fell well short" @BrillResearch on X 2025-07-30 11:12:27 UTC 2640 followers, XXX engagements
"$SOFI delivered stellar earnings Revenue growth surged XX% net income reached $100M EBITDA margin expanded to XX% and (raised) 2025 guidance is bullish across all metrics. The growth story continues to accelerate and $SOFI stock should rebound after digesting the offering" @BrillResearch on X 2025-07-30 09:49:46 UTC 2640 followers, XXX engagements
"$VKTX The combination of advanced clinical assets strong financial backing for Phase X execution and positioning in a high-value therapeutic area makes $VKTX an attractive takeover target particularly if Phase X results demonstrate competitive efficacy and safety profiles" @BrillResearch on X 2025-07-24 11:07:50 UTC 2638 followers, XXX engagements
"$BNTX's valuation is undervalued after the lucrative $BMY deal worth up to $XX billion and BNT327's potential. Once biotech sentiment reverses $BNTX should trade above $200/share driven by its AI capabilities recent acquisitions and over $XX billion in net cash" @BrillResearch on X 2025-07-23 18:58:27 UTC 2638 followers, XXX engagements
"$VKTX Key Operational Highlights - Viking initiated Phase X clinical trials for VK2735 with two VANQUISH studies targeting 1100 adults with type X diabetes who are obese or overweight. - The Phase X clinical program is expected to cost over $XXX million" @BrillResearch on X 2025-07-24 11:07:46 UTC 2638 followers, XXX engagements
"$VKTX had an uneventful ER. Here's a brief summary thread and my takeover target arguments" @BrillResearch on X 2025-07-24 11:07:45 UTC 2638 followers, 1148 engagements
"$AKBA consolidating at a high level. Let's see if it breaks above $X and hits multi-year highs of $X Huge non-dialysis market opportunity for recently approved Vafseo" @BrillResearch on X 2025-07-09 11:14:26 UTC 2639 followers, 1146 engagements
"$UNH Analyst questions also focused on potential settlement costs or reserves related to the DOJ probe. While no specific dollar amount was cited in the Q&A public filings referenced in the earnings report hinted at up to $XXX billion in potential settlement charges. (Positive)" @BrillResearch on X 2025-07-30 11:12:26 UTC 2640 followers, XX engagements
"$MRNA with strong movement today The $35-$36/$40 zone remains a key breakout level with a potential rise to $XX. With 70M shares shorted the chart indicates a clear technical reversal and positive momentum should continue" @BrillResearch on X 2025-07-23 14:20:09 UTC 2638 followers, XXX engagements
"$VKTX Viking Therapeutics Price Target Cut to $122.00/Share From $XXXXXX by Raymond James; Maintained at Strong Buy" @BrillResearch on X 2025-07-28 20:07:03 UTC 2638 followers, XXX engagements
"$UNH revises EPS outlook to $XXXXX. Despite a bearish outlook I believe EPS will bottom in 2025 with growth resuming in 2026. At $XXX the PE ratio is 16x reasonable for mid-single to double-digit EPS growth beyond 2026 and a XXX% dividend yield" @BrillResearch on X 2025-07-30 11:12:24 UTC 2640 followers, XXX engagements